ANVISA and EMA Knowledge
Translators with experience in Brazilian ANVISA submissions and Portuguese EMA/INFARMED regulatory documentation.
The flags show some of the countries and regions where each language is spoken, not a single country of origin.
Brazil is Latin America's largest pharmaceutical market and home to ANVISA, the national health surveillance authority with detailed submission requirements. Portugal operates under EMA frameworks. Our Portuguese medical translators are native speakers with medical or pharmaceutical qualifications and experience with both regulatory environments.
Spoken support for patient consultations and care conferences is covered too, with professional interpreting services working between Portuguese and English. Hospital records and physician letters bound for a US hospital or a hospital in Europe are a separate case, and certified translations for official use can be ordered with the rest of the project. The recipient sets the requirements, so share them early.

Translators with experience in Brazilian ANVISA submissions and Portuguese EMA/INFARMED regulatory documentation.
All Portuguese medical translations handled by translators holding degrees in medicine, pharmacy, or life sciences.
Translation, specialized medical editing, and final terminology review using validated Portuguese medical glossaries.
Patient documents and regulatory materials matched to the correct Portuguese variant for the target market.
“I recently used a translation agency in France to translate several administrative and commercial documents into Spanish.”
“Very polyvalent and capable office. I got assisted and coached very well by Mike to achieve my business goals by implementing an effective approach to AI in the areas…”
“A proactive company, willing to help. I recommend them for website translation and SEO in multiple languages. In my case it was with the WPML plugin.”
Yes. Our Brazilian Portuguese medical translators are familiar with ANVISA technical documentation requirements and the specific formatting conventions for drug registration dossiers.
Yes. We can produce two parallel versions in the same project, one in European Portuguese and one in Brazilian Portuguese, with consistent medical terminology throughout.
We create a project-specific glossary and enforce it consistently using CAT tools and translation memories across all documents in the dossier.
In addition to ANVISA (Brazil) and INFARMED (Portugal), we work with Angola's ARMED (Agencia Reguladora de Medicamentos e Tecnologias de Saude), Mozambique's DNAM (Direccao Nacional de Assistencia Medica) regulatory submissions, and Cape Verde's health authority filings.
For multi-country Lusophone Africa submissions we run a single source pass and adapt terminology to each national authority's conventions in parallel.
Every translator and project manager signs a GDPR-aligned data processing agreement before receiving any patient-identifiable or trial-confidential material. Files are transferred over encrypted channels, processed on secure infrastructure, and purged from our systems on project closure unless you request translation memory retention.
For Brazil-originating projects we apply LGPD (Lei Geral de Protecao de Dados) aligned data handling on top of EU GDPR standard protocols.
Send us your files, language pairs, and deadline. We will confirm specialist availability, certification needs, and a clear quote as quickly as possible.